Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference
24 févr. 2021 08h05 HE
|
Aeterna Zentaris Inc
CHARLESTON, S.C., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing...
Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
19 févr. 2021 13h25 HE
|
Aeterna Zentaris Inc
CHARLESTON, S.C., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and...